| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5079973
Max Phase: Preclinical
Molecular Formula: C16H19N5O
Molecular Weight: 297.36
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: N[C@@H](Cc1c[nH]cn1)C(=O)NCCc1cc2ccccc2[nH]1
Standard InChI: InChI=1S/C16H19N5O/c17-14(8-13-9-18-10-20-13)16(22)19-6-5-12-7-11-3-1-2-4-15(11)21-12/h1-4,7,9-10,14,21H,5-6,8,17H2,(H,18,20)(H,19,22)/t14-/m0/s1
Standard InChI Key: VQEYOZLBJIZNCZ-AWEZNQCLSA-N
Associated Targets(Human)
THOP1 Tbio Thimet oligopeptidase (3 Activities)
MME Tclin Neprilysin (838 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ACE2 Tchem Angiotensin-converting enzyme 2 (190 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ACE Tclin Angiotensin-converting enzyme (1423 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Associated Targets(non-human)
Nln Neurolysin, mitochondrial (179 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 297.36 | Molecular Weight (Monoisotopic): 297.1590 | AlogP: 1.12 | #Rotatable Bonds: 6 |
| Polar Surface Area: 99.59 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 4 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 13.09 | CX Basic pKa: 7.84 | CX LogP: 0.21 | CX LogD: -0.37 |
| Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.55 | Np Likeness Score: -0.44 |
References
| 1. (2020) Enhancers of neurolysin activity, |
| 2. Rahman MS, Kumari S, Esfahani SH, Nozohouri S, Jayaraman S, Kinarivala N, Kocot J, Baez A, Farris D, Abbruscato TJ, Karamyan VT, Trippier PC.. (2021) Discovery of First-in-Class Peptidomimetic Neurolysin Activators Possessing Enhanced Brain Penetration and Stability., 64 (17.0): [PMID:34436882] [10.1021/acs.jmedchem.1c00759] |
Source
Source(2):